Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 15/3/2021
SIETES contiene 93212 citas

 
 
<< anterior 41 a 60 de 365 siguiente >>
Presentar resultados
Seleccionar todas
41. Cita con resumen
Anónimo. Digoxine: gare aux interactions médicamenteuses graves. Prescrire 2009;29:908-11. [Ref.ID 87340]
42.
Gheorghiade M, Braunwald E. Reconsidering the role for digoxin in the management of acute heart failure syndromes. JAMA 2009;302:2146-7. [Ref.ID 87100]
43. Cita con resumen
Nyirenda MJ, Tang JI, Padfield PL, Seckl JR. Hyperkalaemia. BMJ 2009;339:1019-24. [Ref.ID 86996]
44.
Navazio A. Insufficienza cardiaca. Tutto quello che non si può non sapere. Informazioni sui Farmaci 2009;33:70-5. [Ref.ID 86684]
45. Cita con resumen
Krum H, Abraham WT. Heart failure. Lancet 2009;373:941-55. [Ref.ID 85474]
46.Enlace a cita original
Haynes K, Hennessy S, Localio AR, Cohen A, Leornard CE, Kimmel SE, Feldman HI, Strom BL, Metlay JP. Increased risk of digoxin toxicity following hospitalization. Pharmacoepidemiol Drug Saf 2009;18:28-35. [Ref.ID 85179]
47.Tiene citas relacionadas Cita con resumen
Budnitz DS, Shehab N, Kegler SR, Richards CL. Is it safe to conclude that Beers criteria medications led to few adverse events? In response. Ann Intern Med 2008;148:629. [Ref.ID 84900]
48.Tiene citas relacionadas Cita con resumen
Golden A, Beers MH, Fick DM. Is it safe to conclude that Beers criteria medications led to few adverse events?. Ann Intern Med 2008;148:628-9. [Ref.ID 84899]
49. Cita con resumen
50. Cita con resumen
Kildemoes HW, Stovring H, Andersen M. Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological model. Br J Clin Pharmacol 2008;66:885-9. [Ref.ID 84598]
51.
Schwartz JI, Agrawal NGB, Wehling M, Musser BJ, Gumbs CP, Michiels N, De Smet M, Wagner JA. Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib. Br J Clin Pharmacol 2008;66:811-7. [Ref.ID 84597]
52.Enlace a cita original Cita con resumen
Roehr B. Antibiotic top drug reactions in US emergency care visits. BMJ 2008;337:428. [Ref.ID 83830]
53. Cita con resumen
Ruiz B, García M, Aguirre U, Aguirre C. Factors predicting hospital readmissions related to adverse drug reactions. Eur J Clin Pharmacol 2008;64:715-22. [Ref.ID 83516]
54. Cita con resumen
Baxter K, Sharp JM. Adverse drug interactions. Adv Drug React Bull 2008;248:951-4. [Ref.ID 82877]
55. Cita con resumen
Colin JF. Drugs and surgical concerns. BMJ 2008;336:790. [Ref.ID 82652]
56.Tiene citas relacionadas
Aarnoudse ALHJ, Dieleman JP, Stricker BHCH. Age- and gender-specific incidence of hospitalisation for digoxin intoxication. The authors' reply. Drug Saf 2007;30:1173-4. [Ref.ID 81832]
57.Tiene citas relacionadas
Schmiedl S, Szymanski J, Rottenkolber M, Hasford J, Thürmann PA. Age- and gender-specific incidence of hospitalisation for digoxin intoxication. Drug Saf 2007;30:1171-3. [Ref.ID 81831]
58.Tiene citas relacionadas Cita con resumen
Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007;147:755-65. [Ref.ID 81817]
59.
Hernández Martín J, Planells Herrero C, Font Noguera I, Poveda Andrés JL. Diagrama de Ishikawa y análisis de barreras aplicado a un error de medicación que induce rabdomiólisis. Farm Hosp 2007;31:318-20. [Ref.ID 81815]
60.
Pujal Herranz M, Soy Muner D, Nogué Xarau S, Sánchez Sánchez M. Intoxicaciones digitálicas agudas en pacientes de edad avanzada y propuesta de un nomograma de digitalización. Farm Hosp 2007;31:315-6. [Ref.ID 81814]
Seleccionar todas
 
<< anterior 41 a 60 de 365 siguiente >>